US 12,370,229

Application 17/713,975 · Granted Jul 29, 2025

Methods of treating bladder cancer

Estimated expiration

April 13, 2038

11y 146d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Apr 13, 2018
+ 20 years
Apr 13, 2038
PTA +0d
Apr 13, 2038
TD cap (US 11,596,660)
Apr 13, 2038
Final
Apr 13, 2038

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation details

Base term

Filing date
April 5, 2022
Earliest effective filing
April 13, 2018
Issue date
July 29, 2025
PTA
0 days
Base expiry (before PTA)
April 13, 2038

April 13, 2018 + 20 years = April 13, 2038

  • Continuation of application 16/605,066, filed Oct 14, 2019, issued as US 11,338,003
  • National stage entry of application PCTUS2018027549, filed Apr 13, 2018
  • National stage entry of application PCTUS2018027549, filed Apr 13, 2018
  • PRO62/485,805 — Provisional — not used for base term
  • PRO62/500,729 — Provisional — not used for base term
  • PRO62/500,729 — Provisional — not used for base term
  • PRO62/485,805 — Provisional — not used for base term
  • PRO62/500,729 — Provisional — not used for base term
  • PRO62/485,805 — Provisional — not used for base term

Terminal disclaimers

TD approved2 approved, 2 filed

TD caps expiration to April 13, 2038 (earliest expiring referenced patent: US 11,596,660)

  • US 11,338,003· Application 16/605,066Capping patent

    Methods of treating bladder cancer with an oncolytic virus

    Filing date
    Oct 14, 2019
    Earliest effective filing
    Apr 13, 2018
    Issue date
    May 24, 2022
    PTA
    +294 days
    Calculated expiration
    Feb 1, 2039

    National stage entry of PCTUS2018027549, filed Apr 13, 2018

    Apr 13, 2018 + 20y + 294d PTA = Feb 1, 2039

  • US 11,596,660· Application 17/842,406Capping patent

    Methods of treating bladder cancer

    Filing date
    Jun 16, 2022
    Earliest effective filing
    Apr 13, 2018
    Issue date
    Mar 7, 2023
    PTA
    0 days
    Calculated expiration
    Apr 13, 2038

    Continuation of 17/713,975, filed Apr 5, 2022, issued as US 12,370,229

    Continuation of 16/605,066, filed Oct 14, 2019, issued as US 11,338,003

    National stage entry of PCTUS2018027549, filed Apr 13, 2018

    National stage entry of PCTUS2018027549, filed Apr 13, 2018

    Continuation of 16/605,066, filed Oct 14, 2019, issued as US 11,338,003

    National stage entry of PCTUS2018027549, filed Apr 13, 2018

    Apr 13, 2018 + 20y = Apr 13, 2038

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 17/713,975 · US 12,370,229

PatentReply compiles the prosecution history behind US 12,370,229: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12370229

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.